Cleared Special

K082513 - ONETOUCH VITA BLOOD GLUCOSE MONITORING ...

K082513 is the FDA 510(k) clearance for ONETOUCH VITA BLOOD GLUCOSE MONITORING ... by Lifescan, Inc.. It is a Class 2 Chemistry device (product code NBW) cleared through the Special 510(k) pathway after a 50-day FDA review.

K082513 · Lifescan, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2008
Decision
50d
Days
Class 2
Risk

K082513 is an FDA 510(k) clearance for the ONETOUCH VITA BLOOD GLUCOSE MONITORING SYSTEM. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Lifescan, Inc. (Milpitas, US). The FDA issued a Cleared decision on October 22, 2008 after a review of 50 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Lifescan, Inc. devices

Submission Details

510(k) Number K082513 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 02, 2008
Decision Date October 22, 2008
Days to Decision 50 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
38d faster than avg
Panel avg: 88d · This submission: 50d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 183
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K082513.
FORA V12 NO-CODING BLOOD GLUCOSE MONITORING SYSTEM, MODEL TD-4247
K090536 · Taidoc Technology Corporation · Mar 2009
FORA TD-4244 & TD-4245 BLOOD GLUCOSE MONITORING SYSTESM
K081715 · Taidoc Technology Corporation · Dec 2008
PRO GLUCOSE TEST STRIP
K082169 · Taidoc Technology Corporation · Dec 2008
ULTRA TRAK PRO BLOOD GLUCOSE MONITORING SYSTEM, MODEL TD-455
K082618 · Taidoc Technology Corporation · Oct 2008
U-RIGHT TD-4247 BLOOD GLUCOSE MONITORING SYSTEM
K081957 · Taidoc Technology Corporation · Aug 2008
AG-605 BLOOD GLUCOSE MONITORING SYSTEM
K073030 · Andon Health Co, Ltd. · Jul 2008